Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy

Leuk Lymphoma. 2026 Jan 29:1-5. doi: 10.1080/10428194.2026.2621825. Online ahead of print.
No abstract available